Quentir Insights
Evidence-based quantum insights for boards, policy leaders, and investors.
Board-ready Signature Reports and Briefs on where quantum governance and the post-quantum transition are heading, with the lead time to act. Two Evidence Registers on how far quantum medicine and quantum defense have really come, with a Technology Readiness Level on every entry.
Three ways in
Where do you want to start?
Board reports
Signature Reports and Signature Briefs for boards, general counsel, and strategy teams deciding on the post-quantum transition, quantum governance, and the quantum-AI convergence.
See the reports → 02Quantum Medicine
For investors, research leaders, and hospital boards who want to know how far quantum sensing, imaging, simulation, and drug discovery have come on their way to the clinic.
Read the free Medicine Monitor → 03Quantum Defense
For security leaders, policy staff, and defense-industry boards who follow quantum security, secure communications, and sensing from lab to battlefield.
Read the free Defense Monitor →Two monitored fields
Follow both fields for free, every day. The Evidence Registers hold the evidence behind every result.
Quentir Medicine
Quantum technology in medicine
Quantum medicine is moving from lab bench to bedside, and the free Quentir Medicine Monitor follows it for you: trusted insights on the breakthroughs, trials, and results that deserve your attention, each with its Technology Readiness Level (TRL).
Quentir Defense
Quantum defense and security
Quantum security is becoming a board matter, and the free Quentir Defense Monitor follows it for you daily: evidence-based insights on cybersecurity, dual-use technology, secure communications, and the quantum-AI convergence, each capability with its TRL.
Why this exists
Monthly movement, board-level consequences.
Boards, general counsel, and strategy teams are asked to take positions on a legal-technical frontier that moves monthly: transparency duties that already bind, migration calendars that converge on 2030 and 2035, and hardware estimates that compressed a decade into years. Our coverage addresses the questions that matter most: what these technologies mean for American values, democracy, and liberty. A Signature Report or Brief answers the question in front of your board, and a Register entry shows you the evidence behind the result.
Domains covered
- Biomedical discovery
- Quantum innovation strategy
- Quantum governance
- Post-quantum transition
- Critical minerals & materials
- Supply chain resilience
- Cybersecurity
- Dual-Use
- Defense
- Quantum-AI Convergence
- Standards & policy
- Regulatory foresight
- Board-level risk
- Liberal-democratic values
- Abundance
Free and paid, side by side
One Register entry, shown the way members see it.
The free Monitors follow the field for you and note the readiness level of each result. A Register entry goes one step further: the evidence behind the result, what was actually demonstrated, the limitations the authors themselves mention, where it stands on the road from research paper to clinic, and how our reading has evolved since.
Hybrid quantum–classical dose estimation for adaptive radiotherapy
Original claim
A hybrid quantum–classical system reports an 8–15× speedup over classical Monte Carlo simulation for patient-specific dose estimation, with a 50–70% lower mean absolute error. Lal, Singh, Nishad & Khalid, Scientific Reports, June 6, 2025.
Demonstrated result
A computational study. The paper reports these figures for its selected datasets and comparison setup. The linked public repository, checked July 16, 2026, contained pseudocode without executable circuits or timing scripts.
Stated limitations
Idealized patient models and simulated datasets; no comparison with a commercial treatment-planning system; no prospective clinical testing. The authors call for larger multi-institutional datasets and prospective trials.
Sources
Primary: Lal et al., Scientific Reports, June 6, 2025 (open access, PubMed-indexed). Also drawn on: the public repository linked by the paper (checked July 16, 2026); Andreo, Radiation Oncology, 2018.
Evidence-ladder position
A reported computational result, pending independent reproduction. Reproduction comes before commercial-system comparison, multi-center validation, and prospective performance.
Where to start
Start with one edition, or read everything Quentir publishes.
Reports and Briefs are digital downloads (PDF) with a single-organization internal-use license; Radar is a weekly subscription. A sample is open for each kind of product, so you can read before you buy.
Signature Report · No. 3 · Q3 2026
Quantum–AI Convergence After the June 2026 U.S. Quantum Orders
For boards and general counsel that must respond to the two June 22, 2026 executive orders.
- EO 14412 and EO 14413 read against the primary text: deadlines, scope, and what is scheduled versus live;
- the PQC misconceptions that distort migration spending, each corrected against the primary text;
- a Deep Dive on the 10,000-qubit floor behind the deadlines.
Signature Brief · 2026.9 · September 2026
October 19 Comes Before 2030
For security, procurement, and compliance leads with a post-quantum calendar to keep this autumn.
- six dates between September 11 and October 22, 2026, each with the artifact to ask for before it;
- four workstreams with an inspectable artifact each, including the certificate re-basing before September 21;
- seven board oversight questions, each with what a good answer looks like.
Weekly digest · Subscription
Quentir Radar
For leaders who want the week in quantum, AI, and post-quantum governance read for them.
- the week across five topics in a calm ten-minute read: governance, the PQC transition, supply chains, quantum-AI, and board oversight;
- developments from Washington, Brussels, and the Asia-Pacific in one place;
- the deadlines and decision points that matter for your board.
Access
Free, per edition, or all-access: three ways to read Quentir.
All-access membership
- 12 Signature Briefs and 4 Signature Reports a year
- Both Evidence Registers, Radar, and one Scanner assessment included
- Full archive for the duration of your subscription
Signature Reports & Briefs
- Signature Brief: $900 per edition, 12 a year
- Signature Report: $7,500 per edition, 4 a year
- Board-ready and evidence-based; buy any single edition
Free brief & checklist
- The Quantum-Ethics Brief, a free download
- The Article 50 Disclosure Readiness Checklist
- A free daily blog
- The free Quentir Medicine Monitor and Quentir Defense Monitor
- Our newsletter for updates
Each Evidence Register is also available on its own: $1,490 a year, or $149 a month, cancel any time. The choice between monthly and yearly is made at checkout.
Questions boards ask
Who publishes it, whether you can cite it, and how current it is.
Who publishes this?
Quentir Systems LLC publishes Quentir Insights. Every Brief and Report builds on the founder’s published scholarship and the primary texts it discusses, and closes with a full source list.
Can we cite it?
Yes, and it is written to be cited. Take it straight into a board paper, a memo to your counsel, or a conversation with your regulator; each edition closes with the sources it rests on.
Is this advice on our specific case?
By design, it is published insights: the same trusted read every subscriber gets, built to inform your own decisions and the conversations you bring to your board and counsel. For advice on your specific case, your own qualified advisers remain the right call.
How current is it?
Quentir publishes on a fixed cadence: a Signature Brief every month and a Signature Report every quarter, each written from the newest academic, industry, and policy sources. All-access members receive them all; single editions are sold separately. Each edition tells you when it was written, and the quarterly reports say inside when it is time to look again.
Research foundation
Founder
Mauritz Kop
Mauritz Kop is Quentir’s founder. He founded the Stanford Center for Responsible Quantum Technology and was its Founding Director at Stanford Law School from 2023 to 2025. Current roles: Senior Fellow and Principal Investigator at CIGI; Guest Professor at the U.S. Air Force Academy; Subject Matter Expert at the NATO Strategic Communications Centre of Excellence; quantum-ecosystem expert on the von Neumann Commission.
Quentir’s method is grounded in his published frameworks: the LSI test, Hippocratic Quantum, the Bletchley-PQC migration discipline, the Ten Principles for Responsible Quantum Innovation, and Quantum-ELSPI. His work has appeared in Nature Physics, Science, and publications of Stanford, Harvard, Yale, Columbia, and Berkeley. He advised the European Commission during the AI Act process, brought copyright expertise to the European Parliament, briefed U.S. Senators, and consulted for the U.S. Department of State and the Pentagon.
Quentir builds on this scholarship as its research foundation; no institutional endorsement is implied.
Free updates
Hear about each new edition, for free.
We e-mail you when a new Signature Brief, Signature Report, or free download is published. You can unsubscribe with one click.
Subscribe for freeWant the whole week read for you, with the deadlines and decision points? That is Quentir Radar, the paid weekly digest at $59 a month.
Start free
The Quantum-Ethics BriefA Signature Brief special edition: six foundation publications distilled into one working method for healthcare, finance, and dual-use defense, with six artifacts a board can ask for by name.Free download AI Act Article 50 Disclosure Readiness ChecklistA practical 15-question checklist for organizations that generate, publish, or distribute AI-assisted content.Free with your e-mail